QXA
2 FDA 510(k) clearances · Product code
FDA profile
- Official device name
- Lateral Flow Immunochromatography Assay For Host Biomarkers Of Respiratory Infection
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 866.3230
- Medical specialty
- Microbiology
- FDA definition
- A device to detect and measure non-microbial analytes to aid in the detection and identification of localized human infections is identified as an in vitro device intended for the detection and qualitative measurement, quantitative measurement, or both of one or more non-microbial analytes in human clinical specimens to aid in the assessment, identification, or both of a localized microbial infection when used in conjunction with clinical signs and symptoms and other clinical and laboratory findings.
Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free
| Record | Firm | Date |
|---|---|---|
| FebriDx Bacterial/Non-bacterial Assay (K260787) | Lumos Diagnostics, Inc. | 2026-03-24 |
| FebriDx Bacterial / Non-bacterial Point of Care Assay (K230917) | Lumos Diagnostics, Inc. | 2023-06-30 |
Track QXA automatically
Every clearance here is in the API, with alerts when new ones post.